Antilipolytic activity of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (Practolol).
D000083:Acetanilides / Q000494:pharmacology*; D000273:Adipose Tissue / Q000378:metabolism*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors; D000473:Alkanes / Q000037:antagonists & inhibitors; D000818:Animals; D002245:Carbon Dioxide / Q000032:analysis; D002247:Carbon Isotopes; D046508:Culture Techniques; D000242:Cyclic AMP / Q000037:antagonists & inhibitors; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D050356:Lipid Metabolism; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000473:Alkanes; D002247:Carbon Isotopes; D013565:Sympatholytics; D002245:Carbon Dioxide; D000324:Adrenocorticotropic Hormone; D011433:Propranolol; D000242:Cyclic AMP; D005947:Glucose; D007545:Isoproterenol; D005990:Glycerol